| pubmed-article:20574851 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20574851 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:20574851 | lifeskim:mentions | umls-concept:C0009924 | lld:lifeskim |
| pubmed-article:20574851 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
| pubmed-article:20574851 | lifeskim:mentions | umls-concept:C1537028 | lld:lifeskim |
| pubmed-article:20574851 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:20574851 | pubmed:dateCreated | 2011-5-5 | lld:pubmed |
| pubmed-article:20574851 | pubmed:abstractText | The purpose of this study was to demonstrate a novel protein-based magnetic resonance imaging (MRI) contrast agent that has the capability of targeting prostate cancer and which provides high-sensitivity MR imaging in tumor cells and mouse models. | lld:pubmed |
| pubmed-article:20574851 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20574851 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20574851 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20574851 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20574851 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20574851 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20574851 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20574851 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20574851 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20574851 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20574851 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20574851 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20574851 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20574851 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:20574851 | pubmed:issn | 1860-2002 | lld:pubmed |
| pubmed-article:20574851 | pubmed:author | pubmed-author:OrrE CEC | lld:pubmed |
| pubmed-article:20574851 | pubmed:author | pubmed-author:HuXiaopingX | lld:pubmed |
| pubmed-article:20574851 | pubmed:author | pubmed-author:LiuZhi-RenZR | lld:pubmed |
| pubmed-article:20574851 | pubmed:author | pubmed-author:YangJenny JJJ | lld:pubmed |
| pubmed-article:20574851 | pubmed:author | pubmed-author:YeYimingY | lld:pubmed |
| pubmed-article:20574851 | pubmed:author | pubmed-author:ZurkiyaOmarO | lld:pubmed |
| pubmed-article:20574851 | pubmed:author | pubmed-author:LongRobertR | lld:pubmed |
| pubmed-article:20574851 | pubmed:author | pubmed-author:WangLiyaL | lld:pubmed |
| pubmed-article:20574851 | pubmed:author | pubmed-author:ZhaoTiejunT | lld:pubmed |
| pubmed-article:20574851 | pubmed:author | pubmed-author:YangJianhuaJ | lld:pubmed |
| pubmed-article:20574851 | pubmed:author | pubmed-author:ZouJinJ | lld:pubmed |
| pubmed-article:20574851 | pubmed:author | pubmed-author:LiShunyiS | lld:pubmed |
| pubmed-article:20574851 | pubmed:author | pubmed-author:QiaoJingjuanJ | lld:pubmed |
| pubmed-article:20574851 | pubmed:author | pubmed-author:WeiLixiaL | lld:pubmed |
| pubmed-article:20574851 | pubmed:author | pubmed-author:CastiblancoAd... | lld:pubmed |
| pubmed-article:20574851 | pubmed:author | pubmed-author:ChenYanyiY | lld:pubmed |
| pubmed-article:20574851 | pubmed:author | pubmed-author:JohnsonJulian... | lld:pubmed |
| pubmed-article:20574851 | pubmed:author | pubmed-author:ZhouWangdaW | lld:pubmed |
| pubmed-article:20574851 | pubmed:author | pubmed-author:MaorNatalieN | lld:pubmed |
| pubmed-article:20574851 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20574851 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:20574851 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20574851 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20574851 | pubmed:pagination | 416-23 | lld:pubmed |
| pubmed-article:20574851 | pubmed:meshHeading | pubmed-meshheading:20574851... | lld:pubmed |
| pubmed-article:20574851 | pubmed:meshHeading | pubmed-meshheading:20574851... | lld:pubmed |
| pubmed-article:20574851 | pubmed:meshHeading | pubmed-meshheading:20574851... | lld:pubmed |
| pubmed-article:20574851 | pubmed:meshHeading | pubmed-meshheading:20574851... | lld:pubmed |
| pubmed-article:20574851 | pubmed:meshHeading | pubmed-meshheading:20574851... | lld:pubmed |
| pubmed-article:20574851 | pubmed:meshHeading | pubmed-meshheading:20574851... | lld:pubmed |
| pubmed-article:20574851 | pubmed:meshHeading | pubmed-meshheading:20574851... | lld:pubmed |
| pubmed-article:20574851 | pubmed:meshHeading | pubmed-meshheading:20574851... | lld:pubmed |
| pubmed-article:20574851 | pubmed:meshHeading | pubmed-meshheading:20574851... | lld:pubmed |
| pubmed-article:20574851 | pubmed:meshHeading | pubmed-meshheading:20574851... | lld:pubmed |
| pubmed-article:20574851 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:20574851 | pubmed:articleTitle | Protein-based MRI contrast agents for molecular imaging of prostate cancer. | lld:pubmed |
| pubmed-article:20574851 | pubmed:affiliation | Department of Chemistry and Biology, Georgia State University, Atlanta, GA 30302, USA. | lld:pubmed |
| pubmed-article:20574851 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20574851 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
